Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Events

  Events

July 2013
Scientific News
Label-Free Binding Analysis Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Vitamin E Keeps Muscles Healthy
Body builders have it right: vitamin E does help build strong muscles, and scientists appear to have figured out one important way it does it.
Microchip Captures Clusters of Circulating Tumor Cells
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads.
New Method For Measuring The Concentration Of Medicines In The Blood
Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood.
Alternate Administration Routes for Psychotropic Drugs Reviewed
A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.
Epilepsy Drug Metabolism Test Launched for Epilepsy and Seizure Disorders
Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.
Supercooling May Aid Drug Delivery
A new study published is the first to break down the rules governing the complex process of crystallization through rapid-cooling.
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Neuropsychiatric Drug Candidate Shows Good Safety & Tolerability
Transition Therapeutics announces results from Phase 1 AME & renal clearance clinical studies of neuropsychiatric drug candidate ELND005.
International Congress of Toxicology
30 Jun 2013 - 04 Jul 2013
Coex, Seoul, Korea
International Congress of Toxicology
More information
SMi Pharmacovigilance
01 Jul 2013 - 02 Jul 2013
London, UK
SMi Pharmacovigilance
More information
01 Jul 2013 - 02 Jul 2013
London, UK
Pharmacokinetics in Drug Development - for the Non-Specialist
More information
A lesson for cell-signaling studies using advanced detection techniques
02 Jul 2013 - 02 Jul 2013
Webinar
A lesson for cell-signaling studies using advanced detection techniques
More information
Cell Culture
03 Jul 2013 - 04 Jul 2013
London, UK
Cell Culture
More information
The Many Faces of Drug Metabolism
07 Jul 2013 - 12 Jul 2013
Holderness, NH, USA
The Many Faces of Drug Metabolism
More information
8th Annual ADMET Conference
10 Jul 2013 - 11 Jul 2013
London, UK
8th Annual ADMET Conference
More information
ICMGP 2013 11th International Conference on Mercury as a Global Pollutant
28 Jul 2013 - 02 Aug 2013
Edinburgh, Scotland
ICMGP 2013 11th International Conference on Mercury as a Global Pollutant
More information


Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters